PPAR-Gamma in Ulcerative Colitis: A Novel Target for Intervention

E-ISSN： 1873-5592|14|12|1501-1507

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.12, 2013-11, pp. : 1501-1507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docking, Synthesis and Anti-Diabetic Activity of Novel Sulfonylhydrazone Derivatives Designed as PPAR-Gamma Agonists

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 19, 2012-10 ,pp. : 2037-2048

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapies in the treatment of ulcerative colitis

By Tuvlin Jeffrey A Kane Sunanda V

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 483-490

Informa Healthcare

Access to resources Recommend Favorite

Novel therapies in the treatment of ulcerative colitis

By Kane Sunanda V

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1223-1229

Informa Healthcare

Access to resources Recommend Favorite

Novel Pharmacologic Approaches to the Prevention and Treatment of Ulcerative Colitis

Current Pharmaceutical Design, Vol. 19, Iss. 1, 2013-01 ,pp. : 17-28

Bentham Science Publishers

Access to resources Recommend Favorite

Rosiglitazone: novel therapy for ulcerative colitis?

Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite